pharma Β· Duchenne Muscular Dystrophy Β· Muscular Dystrophy, Duchenne Β· SRPT
Sarepta Therapeutics
Sarepta Therapeutics clinical programs β 12 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 215 First Street, Cambridge, MA 02142, US
- Employees
- 1,150
- Programs
- 46
- Drugs
- 23
- Patents
- 102
Sarepta Therapeutics projects
12 ClinicalTrials.gov programs sponsored by Sarepta Therapeutics.
Sarepta Therapeutics has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
4045-301
Sarepta Therapeutics
Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping.
1 trial -
Casimersen
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
Delandistrogene moxeparvovec-rokl
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
ETEPLIRSEN (AVI-4658)
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
Eteplirsen
Sarepta Therapeutics
Muscular Dystrophy, Duchenne
2 trials -
SRP-4045
Sarepta Therapeutics
Duchenne Muscular Dystrophy
2 trials -
SRP-9001-303
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
SRP-9003
Sarepta Therapeutics
Limb-girdle Muscular Dystrophy
2 trials -
SRP-9003-301
Sarepta Therapeutics
Limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4) or Ξ²-sarcoglycanopathy
1 trial -
SRP-9005
Sarepta Therapeutics
Muscular Dystrophies, Limb-Girdle
1 trial -
delandistrogene moxeparvovec
Sarepta Therapeutics
Duchenne Muscular Dystrophy
7 trials -
eteplirsen
Sarepta Therapeutics
Duchenne Muscular Dystrophy (DMD)
2 trials
Frequently asked questions
How many clinical projects does Sarepta Therapeutics have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.